Top-Down Infliximab Study in Kids with Crohn's disease (TISKids)

Phase 4

Recruiting

• Conditions: Crohn's disease; Inflammatory bowel disease; 10017969

• Registration Number: NL-OMON52984
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Diagnosed with Crohn's disease,
Moderate-to-severe disease activity
Aged 3-17
Untreated

Exclusion Criteria

Need for surgery
Severe comorbidity or severe infection
Active perianal fistulas
Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical remission at 52 weeks without need for additional CD related therapy<br /><br>or surgery. </p><br>